New York, April 26, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Therapeutic Drug Monitoring Industry" - https://www.reportlinker.com/p06033114/?utm_source=GNW
4 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at aCAGR of 5.7% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 6.1% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Equipment segment is readjusted to a revised 5.2% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $368 Million, While China is Forecast to Grow at 8.8% CAGR
- The Therapeutic Drug Monitoring market in the U.S. is estimated at US$368 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$423.7 Million by the year 2027 trailing a CAGR of 8.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

- Select Competitors (Total 42 Featured) -




Read the full report: https://www.reportlinker.com/p06033114/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Therapeutic Drug
Monitoring by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Therapeutic Drug Monitoring
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Therapeutic Drug
Monitoring by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2020 & 2027

Table 4: World Current & Future Analysis for Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Consumables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Equipment by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Equipment by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Equipment by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Immunoassays by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Immunoassays by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Immunoassays by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Chromatography-MS
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Chromatography-MS by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Chromatography-MS by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Hospital
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Hospital Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Hospital Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Commercial /
Private Laboratories by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Commercial / Private
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Commercial / Private
Laboratories by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 22: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 25: USA Current & Future Analysis for Therapeutic Drug
Monitoring by Product - Consumables and Equipment - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 26: USA Historic Review for Therapeutic Drug Monitoring
by Product - Consumables and Equipment Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 27: USA 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2020 & 2027

Table 28: USA Current & Future Analysis for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Therapeutic Drug Monitoring
by Technology - Immunoassays and Chromatography-MS Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2020 &
2027

Table 31: USA Current & Future Analysis for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 32: USA Historic Review for Therapeutic Drug Monitoring
by End-Use - Hospital Laboratories, Commercial / Private
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 33: USA 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2020 & 2027

CANADA
Table 34: Canada Current & Future Analysis for Therapeutic Drug
Monitoring by Product - Consumables and Equipment - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 35: Canada Historic Review for Therapeutic Drug
Monitoring by Product - Consumables and Equipment Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 36: Canada 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2020 & 2027

Table 37: Canada Current & Future Analysis for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2020 &
2027

Table 40: Canada Current & Future Analysis for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 41: Canada Historic Review for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 42: Canada 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2020 & 2027

JAPAN
Table 43: Japan Current & Future Analysis for Therapeutic Drug
Monitoring by Product - Consumables and Equipment - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 44: Japan Historic Review for Therapeutic Drug Monitoring
by Product - Consumables and Equipment Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 45: Japan 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2020 & 2027

Table 46: Japan Current & Future Analysis for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: Japan Historic Review for Therapeutic Drug Monitoring
by Technology - Immunoassays and Chromatography-MS Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 48: Japan 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2020 &
2027

Table 49: Japan Current & Future Analysis for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 50: Japan Historic Review for Therapeutic Drug Monitoring
by End-Use - Hospital Laboratories, Commercial / Private
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 51: Japan 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2020 & 2027

CHINA
Table 52: China Current & Future Analysis for Therapeutic Drug
Monitoring by Product - Consumables and Equipment - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 53: China Historic Review for Therapeutic Drug Monitoring
by Product - Consumables and Equipment Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 54: China 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2020 & 2027

Table 55: China Current & Future Analysis for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: China Historic Review for Therapeutic Drug Monitoring
by Technology - Immunoassays and Chromatography-MS Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 57: China 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2020 &
2027

Table 58: China Current & Future Analysis for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 59: China Historic Review for Therapeutic Drug Monitoring
by End-Use - Hospital Laboratories, Commercial / Private
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 60: China 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2020 & 2027

EUROPE
Table 61: Europe Current & Future Analysis for Therapeutic Drug
Monitoring by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 62: Europe Historic Review for Therapeutic Drug
Monitoring by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 63: Europe 15-Year Perspective for Therapeutic Drug
Monitoring by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2020 & 2027

Table 64: Europe Current & Future Analysis for Therapeutic Drug
Monitoring by Product - Consumables and Equipment - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 65: Europe Historic Review for Therapeutic Drug
Monitoring by Product - Consumables and Equipment Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 66: Europe 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2020 & 2027

Table 67: Europe Current & Future Analysis for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2020 &
2027

Table 70: Europe Current & Future Analysis for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 71: Europe Historic Review for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 72: Europe 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2020 & 2027

FRANCE
Table 73: France Current & Future Analysis for Therapeutic Drug
Monitoring by Product - Consumables and Equipment - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 74: France Historic Review for Therapeutic Drug
Monitoring by Product - Consumables and Equipment Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 75: France 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2020 & 2027

Table 76: France Current & Future Analysis for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 77: France Historic Review for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 78: France 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2020 &
2027

Table 79: France Current & Future Analysis for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 80: France Historic Review for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 81: France 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2020 & 2027

GERMANY
Table 82: Germany Current & Future Analysis for Therapeutic
Drug Monitoring by Product - Consumables and Equipment -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 83: Germany Historic Review for Therapeutic Drug
Monitoring by Product - Consumables and Equipment Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 84: Germany 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2020 & 2027

Table 85: Germany Current & Future Analysis for Therapeutic
Drug Monitoring by Technology - Immunoassays and
Chromatography-MS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 86: Germany Historic Review for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 87: Germany 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2020 &
2027

Table 88: Germany Current & Future Analysis for Therapeutic
Drug Monitoring by End-Use - Hospital Laboratories, Commercial
/ Private Laboratories and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 89: Germany Historic Review for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 90: Germany 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2020 & 2027

ITALY
Table 91: Italy Current & Future Analysis for Therapeutic Drug
Monitoring by Product - Consumables and Equipment - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 92: Italy Historic Review for Therapeutic Drug Monitoring
by Product - Consumables and Equipment Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 93: Italy 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2020 & 2027

Table 94: Italy Current & Future Analysis for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: Italy Historic Review for Therapeutic Drug Monitoring
by Technology - Immunoassays and Chromatography-MS Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 96: Italy 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2020 &
2027

Table 97: Italy Current & Future Analysis for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 98: Italy Historic Review for Therapeutic Drug Monitoring
by End-Use - Hospital Laboratories, Commercial / Private
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 99: Italy 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 100: UK Current & Future Analysis for Therapeutic Drug
Monitoring by Product - Consumables and Equipment - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 101: UK Historic Review for Therapeutic Drug Monitoring
by Product - Consumables and Equipment Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 102: UK 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2020 & 2027

Table 103: UK Current & Future Analysis for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 104: UK Historic Review for Therapeutic Drug Monitoring
by Technology - Immunoassays and Chromatography-MS Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 105: UK 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2020 &
2027

Table 106: UK Current & Future Analysis for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 107: UK Historic Review for Therapeutic Drug Monitoring
by End-Use - Hospital Laboratories, Commercial / Private
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 108: UK 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2020 & 2027

SPAIN
Table 109: Spain Current & Future Analysis for Therapeutic Drug
Monitoring by Product - Consumables and Equipment - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 110: Spain Historic Review for Therapeutic Drug
Monitoring by Product - Consumables and Equipment Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 111: Spain 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2020 & 2027

Table 112: Spain Current & Future Analysis for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 113: Spain Historic Review for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 114: Spain 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2020 &
2027

Table 115: Spain Current & Future Analysis for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 116: Spain Historic Review for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 117: Spain 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2020 & 2027

RUSSIA
Table 118: Russia Current & Future Analysis for Therapeutic
Drug Monitoring by Product - Consumables and Equipment -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 119: Russia Historic Review for Therapeutic Drug
Monitoring by Product - Consumables and Equipment Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 120: Russia 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2020 & 2027

Table 121: Russia Current & Future Analysis for Therapeutic
Drug Monitoring by Technology - Immunoassays and
Chromatography-MS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 122: Russia Historic Review for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 123: Russia 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2020 &
2027

Table 124: Russia Current & Future Analysis for Therapeutic
Drug Monitoring by End-Use - Hospital Laboratories, Commercial
/ Private Laboratories and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 125: Russia Historic Review for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 126: Russia 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 127: Rest of Europe Current & Future Analysis for
Therapeutic Drug Monitoring by Product - Consumables and
Equipment - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 128: Rest of Europe Historic Review for Therapeutic Drug
Monitoring by Product - Consumables and Equipment Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 129: Rest of Europe 15-Year Perspective for Therapeutic
Drug Monitoring by Product - Percentage Breakdown of Value
Sales for Consumables and Equipment for the Years 2012, 2020 &
2027

Table 130: Rest of Europe Current & Future Analysis for
Therapeutic Drug Monitoring by Technology - Immunoassays and
Chromatography-MS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 131: Rest of Europe Historic Review for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 132: Rest of Europe 15-Year Perspective for Therapeutic
Drug Monitoring by Technology - Percentage Breakdown of Value
Sales for Immunoassays and Chromatography-MS for the Years
2012, 2020 & 2027

Table 133: Rest of Europe Current & Future Analysis for
Therapeutic Drug Monitoring by End-Use - Hospital Laboratories,
Commercial / Private Laboratories and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 134: Rest of Europe Historic Review for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 135: Rest of Europe 15-Year Perspective for Therapeutic
Drug Monitoring by End-Use - Percentage Breakdown of Value
Sales for Hospital Laboratories, Commercial / Private
Laboratories and Other End-Uses for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 136: Asia-Pacific Current & Future Analysis for
Therapeutic Drug Monitoring by Geographic Region - Australia,
India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033114/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________